Total Payments
$817,815
2024 Payments
$35,724
Companies
43
Transactions
1,596
Medicare Patients
6,589
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$644,938 (78.9%)
Travel$86,182 (10.5%)
Consulting$59,302 (7.3%)
Food & Beverage$27,377 (3.3%)
Education$16.34 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $486,113 | 262 | 59.4% |
| Honoraria | $158,825 | 74 | 19.4% |
| Travel and Lodging | $86,182 | 479 | 10.5% |
| Consulting Fee | $59,302 | 26 | 7.3% |
| Food and Beverage | $27,377 | 753 | 3.3% |
| Education | $16.34 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EISAI INC. | $211,741 | 313 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $183,825 | 479 | $0 (2022) |
| SK Life Science, Inc. | $131,526 | 192 | $0 (2024) |
| Neurelis, Inc. | $115,145 | 115 | $0 (2024) |
| UCB, Inc. | $80,691 | 231 | $0 (2024) |
| Lundbeck LLC | $34,939 | 71 | $0 (2018) |
| AQUESTIVE THERAPEUTICS, INC. | $19,521 | 36 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $14,813 | 28 | $0 (2024) |
| CATALYST PHARMACEUTICALS, INC. | $13,942 | 17 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $3,630 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35,724 | 86 | SK Life Science, Inc. ($17,450) |
| 2023 | $79,080 | 146 | Neurelis, Inc. ($27,179) |
| 2022 | $92,677 | 146 | Neurelis, Inc. ($37,660) |
| 2021 | $73,273 | 130 | SK Life Science, Inc. ($31,096) |
| 2020 | $85,734 | 128 | SK Life Science, Inc. ($30,597) |
| 2019 | $100,167 | 227 | EISAI INC. ($75,395) |
| 2018 | $140,175 | 325 | Sunovion Pharmaceuticals Inc. ($74,482) |
| 2017 | $210,984 | 408 | Sunovion Pharmaceuticals Inc. ($79,671) |
All Payment Transactions
1,596 individual payment records from CMS Open Payments — Page 1 of 64
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: Neurology | ||||||
| 12/10/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $140.35 | General |
| Category: Neurology | ||||||
| 12/08/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $92.50 | General |
| Category: NEUROLOGY | ||||||
| 12/08/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Food and Beverage | Cash or cash equivalent | $40.74 | General |
| Category: Neurology | ||||||
| 12/06/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $67.01 | General |
| 12/06/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Neurology | ||||||
| 12/04/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $4.47 | General |
| 11/27/2024 | Neurelis, Inc. | VALTOCO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,265.00 | General |
| Category: EPILEPSY | ||||||
| 11/27/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Honoraria | Cash or cash equivalent | $1,120.00 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $16.28 | General |
| Category: NEUROLOGY | ||||||
| 11/15/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Honoraria | Cash or cash equivalent | $1,120.00 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Central Nervous System | ||||||
| 11/07/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $25.06 | General |
| 11/01/2024 | Otter Pharmaceuticals, LLC | SYMPAZAN (Drug) | Consulting Fee | Cash or cash equivalent | $1,410.00 | General |
| Category: Neurology | ||||||
| 10/31/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $129.33 | General |
| Category: NEUROLOGY | ||||||
| 10/24/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Neurology | ||||||
| 10/17/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: Neurology | ||||||
| 10/09/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $24.96 | General |
| 09/26/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Neurology | ||||||
| 09/23/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $110.24 | General |
| 09/19/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $4,200.00 | General |
| Category: Neurology | ||||||
| 09/19/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | In-kind items and services | $359.96 | General |
| Category: Neurology | ||||||
| 09/19/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | Cash or cash equivalent | $153.14 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,441 | 3,965 | $840,251 | $205,327 |
| 2022 | 13 | 1,554 | 4,393 | $1.0M | $253,134 |
| 2021 | 13 | 1,693 | 4,629 | $1.2M | $294,277 |
| 2020 | 15 | 1,901 | 5,249 | $1.2M | $307,355 |
Total Patients
6,589
Total Services
18,236
Medicare Billing
$1.1M
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 173 | 410 | $361,308 | $67,071 | 18.6% |
| G0453 | Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | Facility | 2023 | 166 | 2,348 | $138,532 | $60,177 | 43.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 178 | $42,008 | $14,741 | 35.1% |
| 95939 | Placement of skin electrodes and measurement of central motor stimulation in arms and legs | Facility | 2023 | 140 | 147 | $58,800 | $13,608 | 23.1% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 94 | 107 | $60,922 | $11,389 | 18.7% |
| 95861 | Needle measurement of electrical activity in arm or leg muscles, 2 extremities | Facility | 2023 | 156 | 163 | $39,935 | $10,462 | 26.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 185 | 188 | $29,600 | $8,186 | 27.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 168 | 176 | $27,280 | $7,595 | 27.8% |
| 95938 | Placement of skin electrodes and measurement of stimulated sites on arms and legs | Facility | 2023 | 145 | 151 | $60,400 | $5,397 | 8.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $4,108 | $1,880 | 45.8% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Facility | 2023 | 35 | 37 | $6,253 | $1,661 | 26.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $5,400 | $1,528 | 28.3% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2023 | 21 | 21 | $3,255 | $903.20 | 27.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 14 | $2,450 | $729.50 | 29.8% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 216 | 603 | $531,388 | $101,204 | 19.0% |
| G0453 | Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | Facility | 2022 | 172 | 2,464 | $145,376 | $64,544 | 44.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 210 | $49,560 | $17,293 | 34.9% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 112 | 131 | $74,586 | $14,271 | 19.1% |
| 95939 | Placement of skin electrodes and measurement of central motor stimulation in arms and legs | Facility | 2022 | 126 | 139 | $55,600 | $13,321 | 24.0% |
| 95861 | Needle measurement of electrical activity in arm or leg muscles, 2 extremities | Facility | 2022 | 162 | 175 | $42,875 | $11,521 | 26.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 229 | 243 | $37,665 | $10,948 | 29.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 166 | 170 | $26,350 | $7,791 | 29.6% |
| 95938 | Placement of skin electrodes and measurement of stimulated sites on arms and legs | Facility | 2022 | 143 | 156 | $62,400 | $5,740 | 9.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $7,200 | $2,676 | 37.2% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Facility | 2022 | 42 | 42 | $7,098 | $1,773 | 25.0% |
About Dr. Amit Verma, MD
Dr. Amit Verma, MD is a Neurology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619958873.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amit Verma, MD has received a total of $817,815 in payments from pharmaceutical and medical device companies, with $35,724 received in 2024. These payments were reported across 1,596 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($486,113).
As a Medicare-enrolled provider, Verma has provided services to 6,589 Medicare beneficiaries, totaling 18,236 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Clinical Neurophysiology, Sleep Medicine
- Location Houston, TX
- Active Since 11/07/2005
- Last Updated 10/18/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1619958873
Products in Payments
- Fycompa (Drug) $207,343
- APTIOM (Drug) $198,420
- VALTOCO (Drug) $115,145
- XCOPRI (Drug) $105,234
- Briviact (Drug) $46,794
- ONFI (Drug) $34,734
- Cenobamate (Drug) $24,836
- SYMPAZAN (Drug) $19,581
- FYCOMPA (Drug) $13,942
- Nayzilam (Drug) $13,870
- Vimpat (Drug) $11,657
- Dayvigo (Drug) $4,050
- RNS System (Device) $1,610
- Fintepla (Drug) $807.32
- EPIDIOLEX (Drug) $805.12
- Neuroblate (Device) $562.59
- Epidiolex (Drug) $397.77
- CREXONT (Drug) $129.33
- ACTIVA (Device) $100.08
- BOTOX THERAPEUTIC (Biological) $93.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Houston
William Ondo, M.d, M.D
Neurology — Payments: $1.5M
Neurology $1.5M
Dr. Annette Howard, Md, MD
Neurology — Payments: $1.2M
Neurology $1.2M
Paul Schulz, M.d, M.D
Neurology — Payments: $943,067
Neurology $943,067
Dr. Randolph Evans, Md, MD
Neurology — Payments: $715,948
Neurology $715,948
Dr. John Volpi, Md, MD
Neurology — Payments: $569,676
Neurology $569,676
Jerry Wolinsky, M.d, M.D
Neurology — Payments: $556,693
Neurology $556,693